Literature DB >> 8647643

Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer.

L C Lai1, H Erbas, T W Lennard, R T Peaston.   

Abstract

Prostate-specific antigen (PSA) is a 33 kDa serine protease which is produced by many different tissues in the body and has been shown to be present in low concentrations in breast milk and in about 30% of breast cancers. The presence of PSA in breast cancers is associated with the presence of steroid-hormone receptors and may be a favourable prognostic indicator. In this study, PSA immunoreactivity was measured in breast cyst fluid obtained from women with palpable breast cysts which is the most common benign breast disease. PSA was found to be present in very low concentrations in breast cyst fluid. In an attempt to understand the possible role of PSA in the breast, the effect of PSA on growth of the hormone-dependent MCF-7 and hormone-independent MDA-MB-231 human breast cancer cell lines was studied. In addition, the effect of PSA on oestrone sulphatase activity and oestrogen 17-oxidoreductase activity in these cell lines was investigated. PSA, in low concentrations, was found to inhibit MCF-7 cell growth and to stimulate the conversion of oestradiol to the less potent oestrogen oestrone in this cell line. PSA had no effect on the MDA-MB-231 cell line. Our findings suggest that PSA may act as a negative growth regulator in hormone-dependent breast cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647643     DOI: 10.1002/(SICI)1097-0215(19960611)66:6<743::AID-IJC6>3.0.CO;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease.

Authors:  M Malatesta; F Mannello; M Sebastiani; G Gazzanelli
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease.

Authors:  G H Borchert; H Yu; G Tomlinson; M Giai; R Roagna; R Ponzone; L Sgro; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 3.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

4.  Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.

Authors:  M H Black; A Magklara; C Obiezu; M A Levesque; D J Sutherland; D J Tindall; C Y Young; E R Sauter; E P Diamandis
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

5.  Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.

Authors:  A Chang; G M Yousef; A Scorilas; L Grass; P Sismondi; R Ponzone; E P Diamandis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640

6.  Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.

Authors:  J A Foekens; E P Diamandis; H Yu; M P Look; M E Meijer-van Gelder; W L van Putten; J G Klijn
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.

Authors:  J Romppanen; R Keskikuru; V Kataja; M Eskelinen; V M Kosma; K Savolainen; M Uusitupa; I Mononen
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

8.  Correlation between KLK6 expression and the clinicopathological features of glioma.

Authors:  Jiangtao Lou; Haiyan Si; Yingjian Chen; Xiaoming Sun; Hua Zhang; Aijun Niu; Chengjin Hu
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-30

9.  Kallikrein gene downregulation in breast cancer.

Authors:  G M Yousef; G M Yacoub; M-E Polymeris; C Popalis; A Soosaipillai; E P Diamandis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.